Blue-Zone Technologies, Ltd., a Toronto, Canada-based Clean-Tech Pharmaceutical company focused on the sustainable capture and recovery of waste anesthetic gasses, resulting in the production of branded generic anesthetics, raised $8m institutional financing.
The round was led by the Canadian Venture Capital arm of Crédit Mutuel Equity (formerly CIC Capital Ventures) and Round Pound Ventures, LLC.
The company intends to use the funds to expand operations and its business reach.
Founded in 1999 by Dusanka Filipovic and led by Kipton Lade, CEO, Blue-Zone Technologies collects unused anesthetics that would normally be vented into the environment and processes the collected material into its pure form providing a sustainable and cost-efficient source of inhalation anesthetic drugs. As such, it is a Cleantech Pharmaceutical Company, running a fully operational, GMP compliant, Health Canada licensed Drug Establishment Facility for Anesthetic Recovery, Raw Material and Final Product Production.
FinSMEs
05/10/2022